Naprius (Naproxen)

Naproxen, the active ingredient in Naprius, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for oral use. It is employed to relieve pain, reduce inflammation, and lower fever in adults experiencing conditions such as arthritis, dysmenorrhea, and other musculoskeletal discomforts.

GNH USA supplies Naprius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable sourcing for healthcare providers across multiple regions, including Europe, Asia and Africa.

Naproxen is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase enzymes. - Pain: Provides symptomatic relief of mild to moderate pain. - Inflammation: Decreases inflammatory response in conditions such as osteoarthritis. - Arthritis: Alleviates joint pain and swelling associated with rheumatoid and osteoarthritis. - Dysmenorrhea: Relieves menstrual cramps and associated discomfort.

Common Side Effects: - Gastrointestinal discomfort such as nausea or dyspepsia. - Headache. - Dizziness. - Mild skin rash.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Acute renal failure or worsening kidney function. - Severe hypersensitivity reactions, including Stevens‑Johnson syndrome.

Before initiating therapy, consider the following precautions: - Assess renal function: monitor in patients with existing kidney disease. - Evaluate gastrointestinal risk: avoid in individuals with a history of ulcer or bleeding. - Consider cardiovascular risk: use cautiously in patients with heart disease. - Avoid in known hypersensitivity to NSAIDs or aspirin. - Use the lowest effective dose for the shortest duration needed. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Naproxen may interact with several drug classes. Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may reduce renal function. - Diuretics: potential for renal impairment. - Lithium: may increase serum lithium levels.